All about health

Baxter International Inc. , a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May...

Mirum Pharmaceuticals, Inc. today announced that data from the Phase 3 MARCH-PFIC study evaluating LIVMARLI® (maralixibat) oral solution in patients with PFIC was published in The Lancet Gastroenterology and Hepatology. The MARCH-PFIC study was...

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 18 abstracts during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. These data showcase the ongoing commitment to developing differentiated approaches to transform...

VIO Med Spa, the leading franchise medical spa, is proud to welcome FJ Management, a renowned leader in operating diverse businesses, to its latest venture into the medical aesthetics industry through their acquisition of the area representative...

During the past year, noted ophthalmologists Drs. Kerry Assil and Avneet Sodhi Gaur of Assil Gaur Eye Institute of Los Angeles implanted hundreds of Odyssey intraocular lenses (IOL) for those who want optimized vision but need cataract surgery or are...

KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene Therapy (C>) Market, is launching GLP Genomic Integrity Karyotyping services at the 2024 American...

Dive deep into the realms of mindfulness and meditation with the latest release from acclaimed author Jenah Victor, "Soul Quest: Discovering Your Divine Destiny". This book is not merely a read; it's an interactive guide crafted to navigate you...

In this free webinar, attendees will gain insights into the challenges of cannabinoid analysis owing to the proliferation of THC analogues and the use of advanced methodologies for accurate analysis. The featured speaker will discuss the analytical...

DarioHealth Corp. , a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 1st quarter ended March 31st, 2024, on Wednesday, May 15th, 2024, before the market opens and will host a...

ACTO today announced the availability of TalkTRxtm, the first product built to provide reps access to marketing assets with overlaid context so they can present accurately and in a more personal way to health care providers (HCPs). TalkTRx from ACTO...

Meridian in Michigan, a leading managed care organization in the state of Michigan and a wholly-owned subsidiary of Centene Corporation and the  Centene Foundation, the philanthropic arm of Centene Corporation, announced today a $1.1 million grant...

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its...

In this free webinar, attendees will gain insights into the current and future trends, opportunities and considerations for the development of inhaled biologics. The featured speakers will discuss factors such as the biologic's dose/regimen,...

Today, the American Cancer Society (ACS) is proud to announce the launch of the VOICES of Black Women® study, the largest behavioral and environmental focused population study of cancer risk and outcomes in Black women in the United States.  Designed...

IceCure Medical Ltd. ("IceCure" or the "Company"), developer of the ProSense® System, a...

Neurocrine Biosciences, Inc. today announced that it will present key information from its neuroendocrinology pipeline,...

In this free webinar, attendees will gain insights into functional and operational aspects of integrated evidence planning (IEP) and the rationale and benefits of IEP. They will hear about the evolution of IEP, future trends and how it meets...

Cellarity, a life sciences company founded by Flagship Pioneering to transform the way medicines are created, today announced the appointment of Christopher ("Topher") Woelk, Ph.D., as Vice President and Head of Platform. In this role, Woelk will...

ImmunityBio, Inc. announced today that the drug substance (DS) has been completed and successfully qualified for "fill finish" (filling vials and finishing packaging), sufficient for 170,000 doses of 400mcg ANKTIVA (nogapendekin alfa...

CG Life, a science-first, tech-enabled agency for life science, has expanded its leadership team to welcome Jon Sawyer as the agency's Chief Operating Officer. Sawyer brings more than 20 years of leadership in healthcare marketing to the role and...

Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that a poster was presented at IMMUNOLOGY2024, the annual meeting of The American...

Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell- and tissue-based therapies, has announced a partnership with Pluristyx, Inc., an early stage, privately held biotechnology company specializing in induced Pluripotent...

Mental wellness programs were the most common type of service requested by veteran family members and caregivers registered with Wounded Warrior Project® (WWP) from October 2022 to October 2023. In recognition of Month of the Military Caregiver and...

ENDRA Life Sciences Inc. (ENDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months ended March 31, 2024 on Tuesday, May 14, 2024 after the close of trading...

Alzamend Neuro, Inc. ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and...

Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has achieved a significant victory in its ongoing legal battle with 10x Genomics and Harvard University. The U.S....

ARTBIO, Inc. (ARTBIO), a clinical-stage radiopharmaceutical company developing a new class of targeted alpha radioligand therapies (ARTs), and Nucleus RadioPharma Inc. (Nucleus), the world's first fully integrated development, manufacturing, and...

Myrtelle Inc. ("Myrtelle" or the "Company"), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases, will host a symposium on Canavan disease (CD) clinical trial updates and future...

Celerion, a leading clinical research organization, specializing in early clinical research and bioanalytical services, today announced the appointment of Jo Goodman as vice president of bioanalytical services in its Lincoln, Nebraska, laboratory....

UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in May: Citizens JMP...